Storia in 3 fonti

Novartis, Ionis Tumble On Surprise Flop For Heart Drug

Novartis' Ionis-partnered Lp(a) blocker failed in testing. Both stocks fell.

Raccontata da

investors.com

swissinfo.ch

biopharmadive.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

investors.comStai leggendo6 g fa

Novartis, Ionis Tumble On Surprise Flop For Heart Drug

Novartis' Ionis-partnered Lp(a) blocker failed in testing. Both stocks fell.

originale

biopharmadive.com6 g fa

Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines

Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a surprise result with important implications for cardiovascular drug research.

Leggi questa versione → originale

Timeline cronologica

venerdì 4 settembre 2026·investors.com
Novartis, Ionis Tumble On Surprise Flop For Heart Drug
Novartis' Ionis-partnered Lp(a) blocker failed in testing. Both stocks fell.
venerdì 4 settembre 2026·swissinfo.ch
Novartis Drug Fails Key Test for New Heart Disease Approach
(Bloomberg) -- A Novartis AG drug billed as a potential blockbuster failed to reduce the risk of heart attacks and strokes in a final-stage trial, marking a major setback for a…

Novartis, Ionis Tumble On Surprise Flop For Heart Drug

Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines

Timeline cronologica

Novartis, Ionis Tumble On Surprise Flop For Heart Drug

Novartis Drug Fails Key Test for New Heart Disease Approach

Novartis Drug Fails Key Test for New Heart Disease Approach

Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines